Stefan H. I. Kappe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stefan H. I. Kappe has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Ashley M. Vaughan
A Center for Infectious Disease Research , Seattle , WA , USA
17 shared publications- Sebastian A. Mikolajczak
Novartis Institute for Tropical Diseases, Novartis Institutes for BioMedical Research
11 shared publications Alexis Kaushansky
Seattle Biomedical Research Institute, 307 Westlake Avenue North, Suite 500, Seattle, WA 98109, USA
10 shared publicationsJessica L. Miller
Seattle Biomedical Research Institute, Seattle, Washington, United States of America
7 shared publicationsNelly Camargo
Center for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, Washington, USA
6 shared publications- Scott E. Lindner
Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park
6 shared publications
Latest Publications
- 1 January 2025
- Published by Springer Nature
- p. 363-372
Fatty Acid Synthesis in the Apicoplast
- Open Access
- 16 June 2017
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 16 (8) , 765-767
Genetically attenuated malaria parasites as vaccines
(2017). Genetically attenuated malaria parasites as vaccines. Expert Review of Vaccines: Vol. 16, No. 8, pp. 765-767.
- 16 June 2017
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 16 (8) , 765-767
Open AccessGenetically attenuated malaria parasites as vaccines
(2017). Genetically attenuated malaria parasites as vaccines. Expert Review of Vaccines: Vol. 16, No. 8, pp. 765-767.
- Open Access
- 1 June 2015
- Published by Springer Nature in Nature Methods
- Vol. 12 (7) , 631-633
Plasmodium falciparum genetic crosses in a humanized mouse model
A human-liver chimeric mouse supports the growth of recombinant Plasmodium falciparum progeny, enabling easy analysis of genetic crosses between parasite strains. Genetic crosses of phenotypically distinct strains of the human malaria parasite Plasmodium falciparum are a powerful tool for identifying genes controlling drug resistance and other key phenotypes. Previous studies relied on the isolation of recombinant parasites from splenectomized chimpanzees, a research avenue that is no longer available. Here we demonstrate that human-liver chimeric mice support recovery of recombinant progeny for the identification of genetic determinants of parasite traits and adaptations.
- 1 June 2015
- Published by Springer Nature in Nature Methods
- Vol. 12 (7) , 631-633
Open AccessPlasmodium falciparum genetic crosses in a humanized mouse model
A human-liver chimeric mouse supports the growth of recombinant Plasmodium falciparum progeny, enabling easy analysis of genetic crosses between parasite strains. Genetic crosses of phenotypically distinct strains of the human malaria parasite Plasmodium falciparum are a powerful tool for identifying genes controlling drug resistance and other key phenotypes. Previous studies relied on the isolation of recombinant parasites from splenectomized chimpanzees, a research avenue that is no longer available. Here we demonstrate that human-liver chimeric mice support recovery of recombinant progeny for the identification of genetic determinants of parasite traits and adaptations.
- Open Access
- 14 May 2015
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 11 (5) , e1004855
Mechanisms of Stage-Transcending Protection Following Immunization of Mice with Late Liver Stage-Arresting Genetically Attenuated Malaria Parasites
Malaria, caused by Plasmodium parasite infection, continues to be one of the leading causes of worldwide morbidity and mortality. Development of an effective vaccine has been encumbered by the complex life cycle of the parasite that has distinct pre-erythrocytic and erythrocytic stages of infection in the mammalian host. Historically, malaria vaccine development efforts have targeted each stage in isolation. An ideal vaccine, however, would target multiple life cycle stages with multiple arms of the immune system and be capable of eliminating initial infection in the liver, the subsequent blood stage infection, and would prevent further parasite transmission. We have previously shown that immunization of mice with Plasmodium yoelii genetically attenuated parasites (GAP) that arrest late in liver stage development elicits stage-transcending protection against both a sporozoite challenge and a direct blood stage challenge. Here, we show that this immunization strategy engenders both T- and B-cell responses that are essential for stage-transcending protection, but the relative importance of each is determined by the host genetic background. Furthermore, potent anti-blood stage antibodies elicited after GAP immunization rely heavily on FC-mediated functions including complement fixation and FC receptor binding. These protective antibodies recognize the merozoite surface but do not appear to recognize the immunodominant merozoite surface protein-1. The antigen(s) targeted by stage-transcending immunity are present in both the late liver stages and blood stage parasites. The data clearly show that GAP-engendered protective immune responses can target shared antigens of pre-erythrocytic and erythrocytic parasite life cycle stages. As such, this model constitutes a powerful tool to identify novel, protective and stage-transcending T and B cell targets for incorporation into a multi-stage subunit vaccine. Malaria is arguably one of the deadliest infectious diseases in human history. Today, it infects nearly 300 million people each year and kills up to 1 million of those—mostly women and children under the age of 5—and no effective malaria vaccine has been developed. Traditional subunit vaccines for pathogens work by training the immune system to recognize a single pathogen target. Attempts at developing a subunit malaria vaccine have, however, been stymied by the complexity of the parasite genome which encodes a complex life cycle with specific stages in the mosquito, as well as in the liver and blood of the mammalian host. Only the blood stage parasites cause malaria symptoms and mortality. Previously, it was assumed that immunity to malaria is stage-specific, either targeting parasites in the liver or in blood, but not both. The herein described vaccination approach uses genetically engineered, attenuated rodent malaria parasites that are able to infect the mouse liver and replicate, but die shortly before red blood-infectious parasite stages are formed and released. Immunization with these attenuated parasites induces the immune system to build defenses against both parasite stages in the liver and blood. Protection is mediated by multiple arms of the immune system. The antibody arm recognizes parasite targets shared between liver stages and blood stages. This not only demonstrates the optimal potency of this live-attenuated vaccination strategy, but also provides a potential source of new malaria subunit vaccine targets.
- 14 May 2015
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 11 (5) , e1004855
Open AccessMechanisms of Stage-Transcending Protection Following Immunization of Mice with Late Liver Stage-Arresting Genetically Attenuated Malaria Parasites
Malaria, caused by Plasmodium parasite infection, continues to be one of the leading causes of worldwide morbidity and mortality. Development of an effective vaccine has been encumbered by the complex life cycle of the parasite that has distinct pre-erythrocytic and erythrocytic stages of infection in the mammalian host. Historically, malaria vaccine development efforts have targeted each stage in isolation. An ideal vaccine, however, would target multiple life cycle stages with multiple arms of the immune system and be capable of eliminating initial infection in the liver, the subsequent blood stage infection, and would prevent further parasite transmission. We have previously shown that immunization of mice with Plasmodium yoelii genetically attenuated parasites (GAP) that arrest late in liver stage development elicits stage-transcending protection against both a sporozoite challenge and a direct blood stage challenge. Here, we show that this immunization strategy engenders both T- and B-cell responses that are essential for stage-transcending protection, but the relative importance of each is determined by the host genetic background. Furthermore, potent anti-blood stage antibodies elicited after GAP immunization rely heavily on FC-mediated functions including complement fixation and FC receptor binding. These protective antibodies recognize the merozoite surface but do not appear to recognize the immunodominant merozoite surface protein-1. The antigen(s) targeted by stage-transcending immunity are present in both the late liver stages and blood stage parasites. The data clearly show that GAP-engendered protective immune responses can target shared antigens of pre-erythrocytic and erythrocytic parasite life cycle stages. As such, this model constitutes a powerful tool to identify novel, protective and stage-transcending T and B cell targets for incorporation into a multi-stage subunit vaccine. Malaria is arguably one of the deadliest infectious diseases in human history. Today, it infects nearly 300 million people each year and kills up to 1 million of those—mostly women and children under the age of 5—and no effective malaria vaccine has been developed. Traditional subunit vaccines for pathogens work by training the immune system to recognize a single pathogen target. Attempts at developing a subunit malaria vaccine have, however, been stymied by the complexity of the parasite genome which encodes a complex life cycle with specific stages in the mosquito, as well as in the liver and blood of the mammalian host. Only the blood stage parasites cause malaria symptoms and mortality. Previously, it was assumed that immunity to malaria is stage-specific, either targeting parasites in the liver or in blood, but not both. The herein described vaccination approach uses genetically engineered, attenuated rodent malaria parasites that are able to infect the mouse liver and replicate, but die shortly before red blood-infectious parasite stages are formed and released. Immunization with these attenuated parasites induces the immune system to build defenses against both parasite stages in the liver and blood. Protection is mediated by multiple arms of the immune system. The antibody arm recognizes parasite targets shared between liver stages and blood stages. This not only demonstrates the optimal potency of this live-attenuated vaccination strategy, but also provides a potential source of new malaria subunit vaccine targets.
- Open Access
- 1 May 2015
- Published by American Society for Microbiology in mBio
- Vol. 6 (2) , e02330
Cyclic GMP Balance Is Critical for Malaria Parasite Transmission from the Mosquito to the Mammalian Host
Transmission of malaria occurs during Anopheles mosquito vector blood meals, when Plasmodium sporozoites that have invaded the mosquito salivary glands are delivered to the mammalian host. Sporozoites display a unique form of motility that is essential for their movement across cellular host barriers and invasion of hepatocytes. While the molecular machinery powering motility and invasion is increasingly well defined, the signaling events that control these essential parasite activities have not been clearly delineated. Here, we identify a phosphodiesterase ( PDE γ) in Plasmodium, a regulator of signaling through cyclic nucleotide second messengers. Reverse transcriptase PCR (RT-PCR) analysis and epitope tagging of endogenous PDEγ detected its expression in blood stages and sporozoites of Plasmodium yoelii . Deletion of PDE γ ( pde γ − ) rendered sporozoites nonmotile, and they failed to invade the mosquito salivary glands. Consequently, PDEγ deletion completely blocked parasite transmission by mosquito bite. Strikingly, pde γ − sporozoites showed dramatically elevated levels of cyclic GMP (cGMP), indicating that a perturbation in cyclic nucleotide balance is involved in the observed phenotypic defects. Transcriptome sequencing (RNA-Seq) analysis of pde γ − sporozoites revealed reduced transcript abundance of genes that encode key components of the motility and invasion apparatus. Our data reveal a crucial role for PDE γ in maintaining the cyclic nucleotide balance in the malaria parasite sporozoite stage, which in turn is essential for parasite transmission from mosquito to mammal. IMPORTANCE Malaria is a formidable threat to human health worldwide, and there is an urgent need to identify novel drug targets for this parasitic disease. The parasite is transmitted by mosquito bite, inoculating the host with infectious sporozoite stages. We show that cellular signaling by cyclic nucleotides is critical for transmission of the parasite from the mosquito vector to the mammalian host. Parasite phosphodiesterase γ is essential for maintaining cyclic nucleotide balance, and its deletion blocks transmission of sporozoites. A deeper understanding of the signaling mechanisms involved in transmission might inform the discovery of novel drugs that interrupt this essential step in the parasite life cycle.
- 1 May 2015
- Published by American Society for Microbiology in mBio
- Vol. 6 (2) , e02330
Open AccessCyclic GMP Balance Is Critical for Malaria Parasite Transmission from the Mosquito to the Mammalian Host
Transmission of malaria occurs during Anopheles mosquito vector blood meals, when Plasmodium sporozoites that have invaded the mosquito salivary glands are delivered to the mammalian host. Sporozoites display a unique form of motility that is essential for their movement across cellular host barriers and invasion of hepatocytes. While the molecular machinery powering motility and invasion is increasingly well defined, the signaling events that control these essential parasite activities have not been clearly delineated. Here, we identify a phosphodiesterase ( PDE γ) in Plasmodium, a regulator of signaling through cyclic nucleotide second messengers. Reverse transcriptase PCR (RT-PCR) analysis and epitope tagging of endogenous PDEγ detected its expression in blood stages and sporozoites of Plasmodium yoelii . Deletion of PDE γ ( pde γ − ) rendered sporozoites nonmotile, and they failed to invade the mosquito salivary glands. Consequently, PDEγ deletion completely blocked parasite transmission by mosquito bite. Strikingly, pde γ − sporozoites showed dramatically elevated levels of cyclic GMP (cGMP), indicating that a perturbation in cyclic nucleotide balance is involved in the observed phenotypic defects. Transcriptome sequencing (RNA-Seq) analysis of pde γ − sporozoites revealed reduced transcript abundance of genes that encode key components of the motility and invasion apparatus. Our data reveal a crucial role for PDE γ in maintaining the cyclic nucleotide balance in the malaria parasite sporozoite stage, which in turn is essential for parasite transmission from mosquito to mammal. IMPORTANCE Malaria is a formidable threat to human health worldwide, and there is an urgent need to identify novel drug targets for this parasitic disease. The parasite is transmitted by mosquito bite, inoculating the host with infectious sporozoite stages. We show that cellular signaling by cyclic nucleotides is critical for transmission of the parasite from the mosquito vector to the mammalian host. Parasite phosphodiesterase γ is essential for maintaining cyclic nucleotide balance, and its deletion blocks transmission of sporozoites. A deeper understanding of the signaling mechanisms involved in transmission might inform the discovery of novel drugs that interrupt this essential step in the parasite life cycle.
- 1 April 2015
- Published by Elsevier in Cell Host & Microbe
- Vol. 17 (4) , 526-535
Plasmodium vivax Liver Stage Development and Hypnozoite Persistence in Human Liver-Chimeric Mice
- 1 April 2015
- Published by Elsevier in Cell Host & Microbe
- Vol. 17 (4) , 526-535
Plasmodium vivax Liver Stage Development and Hypnozoite Persistence in Human Liver-Chimeric Mice
- Open Access
- 1 January 2015
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 83 (1) , 39-47
Susceptibility to Plasmodium yoelii Preerythrocytic Infection in BALB/c Substrains Is Determined at the Point of Hepatocyte Invasion
Virulence of Mycobacterium tuberculosis is intimately related to its distinctive cell wall. Biological significance of poly-α-L-glutamine, a component in the cell wall of virulent mycobacteria has not been explored adequately. The focus of this study is to investigate the role of a locus Rv0574c, coding for polyglutamate synthase like protein, in synthesis of poly-α-L-glutamine in the context of mycobacterial virulence. Evaluation of Rv0574c gene expression in M. tuberculosis demonstrated its growth phase linked induction with concomitant accumulation of poly-α-L-glutamine in the cell wall. Rv0574c was activated under conditions prevalent in the tubercular granuloma e.g. hypoxia, nitric oxide and CO2. For functional characterization, we produced a deletion mutant of the gene Rv0574c by allelic exchange. The mutant produced lower amounts of poly-α-L-glutamine in the cell wall compared to the wild type bacteria. Additionally, increased sensitivity of the mutant to anti-tubercular drugs, SDS, lysozyme and mechanical stress was accompanied with drastic reduction in ability to form biofilm. Growth of the ΔRv0574c strain was normal under in vitro conditions but was retarded in THP-1 macrophages and in the lungs and spleen of BALB/c mice. This was in agreement with histopathology of the lungs showing slow growth and less severe pathology than the wild type strain. In summary, this study demonstrates that the protein encoded by Rv0574c locus by virtue of modulating PLG content in the cell wall, helps in maintaining cellular integrity under hostile host environment. Also, its involvement in protecting the pathogen from host-generated lethal factors contributes to infectious biology of M. tuberculosis.
- 1 January 2015
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 83 (1) , 39-47
Open AccessSusceptibility to Plasmodium yoelii Preerythrocytic Infection in BALB/c Substrains Is Determined at the Point of Hepatocyte Invasion
Virulence of Mycobacterium tuberculosis is intimately related to its distinctive cell wall. Biological significance of poly-α-L-glutamine, a component in the cell wall of virulent mycobacteria has not been explored adequately. The focus of this study is to investigate the role of a locus Rv0574c, coding for polyglutamate synthase like protein, in synthesis of poly-α-L-glutamine in the context of mycobacterial virulence. Evaluation of Rv0574c gene expression in M. tuberculosis demonstrated its growth phase linked induction with concomitant accumulation of poly-α-L-glutamine in the cell wall. Rv0574c was activated under conditions prevalent in the tubercular granuloma e.g. hypoxia, nitric oxide and CO2. For functional characterization, we produced a deletion mutant of the gene Rv0574c by allelic exchange. The mutant produced lower amounts of poly-α-L-glutamine in the cell wall compared to the wild type bacteria. Additionally, increased sensitivity of the mutant to anti-tubercular drugs, SDS, lysozyme and mechanical stress was accompanied with drastic reduction in ability to form biofilm. Growth of the ΔRv0574c strain was normal under in vitro conditions but was retarded in THP-1 macrophages and in the lungs and spleen of BALB/c mice. This was in agreement with histopathology of the lungs showing slow growth and less severe pathology than the wild type strain. In summary, this study demonstrates that the protein encoded by Rv0574c locus by virtue of modulating PLG content in the cell wall, helps in maintaining cellular integrity under hostile host environment. Also, its involvement in protecting the pathogen from host-generated lethal factors contributes to infectious biology of M. tuberculosis.
- Open Access
- 15 December 2014
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 211 (13) , 2482
A novel immune regulator links malaria and inflammatory bowel disease
- 15 December 2014
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 211 (13) , 2482
Open AccessA novel immune regulator links malaria and inflammatory bowel disease
- 1 November 2014
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 82 (11) , 4643-4653
SSP3 Is a Novel Plasmodium yoelii Sporozoite Surface Protein with a Role in Gliding Motility
Plasmodiumsporozoites develop within oocysts in the mosquito midgut wall and then migrate to the salivary glands. After transmission, they embark on a complex journey to the mammalian liver, where they infect hepatocytes. Proteins on the sporozoite surface likely mediate multiple steps of this journey, yet only a few sporozoite surface proteins have been described. Here, we characterize a novel, conserved sporozoite surface protein (SSP3) in the rodent malaria parasitePlasmodium yoelii. SSP3 is a putative type I transmembrane protein unique toPlasmodium. By using epitope tagging and SSP3-specific antibodies in conjunction with immunofluorescence microscopy, we showed that SSP3 is expressed in mosquito midgut oocyst sporozoites, exhibiting an intracellular localization. In sporozoites derived from the mosquito salivary glands, however, SSP3 localized predominantly to the sporozoite surface as determined by immunoelectron microscopy. However, the ectodomain of SSP3 appeared to be inaccessible to antibodies in nonpermeabilized salivary gland sporozoites. Antibody-induced shedding of the major surface protein circumsporozoite protein (CSP) exposed the SSP3 ectodomain to antibodies in some sporozoites. Targeted deletion ofSSP3adversely affectedin vitrosporozoite gliding motility, which, surprisingly, impacted neither their cell traversal capacity, host cell invasionin vitro, nor infectivityin vivo. Together, these data reveal a previously unappreciated complexity of thePlasmodiumsporozoite surface proteome and the roles of surface proteins in distinct biological activities of sporozoites.
- 1 November 2014
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 82 (11) , 4643-4653
SSP3 Is a Novel Plasmodium yoelii Sporozoite Surface Protein with a Role in Gliding Motility
Plasmodiumsporozoites develop within oocysts in the mosquito midgut wall and then migrate to the salivary glands. After transmission, they embark on a complex journey to the mammalian liver, where they infect hepatocytes. Proteins on the sporozoite surface likely mediate multiple steps of this journey, yet only a few sporozoite surface proteins have been described. Here, we characterize a novel, conserved sporozoite surface protein (SSP3) in the rodent malaria parasitePlasmodium yoelii. SSP3 is a putative type I transmembrane protein unique toPlasmodium. By using epitope tagging and SSP3-specific antibodies in conjunction with immunofluorescence microscopy, we showed that SSP3 is expressed in mosquito midgut oocyst sporozoites, exhibiting an intracellular localization. In sporozoites derived from the mosquito salivary glands, however, SSP3 localized predominantly to the sporozoite surface as determined by immunoelectron microscopy. However, the ectodomain of SSP3 appeared to be inaccessible to antibodies in nonpermeabilized salivary gland sporozoites. Antibody-induced shedding of the major surface protein circumsporozoite protein (CSP) exposed the SSP3 ectodomain to antibodies in some sporozoites. Targeted deletion ofSSP3adversely affectedin vitrosporozoite gliding motility, which, surprisingly, impacted neither their cell traversal capacity, host cell invasionin vitro, nor infectivityin vivo. Together, these data reveal a previously unappreciated complexity of thePlasmodiumsporozoite surface proteome and the roles of surface proteins in distinct biological activities of sporozoites.
- Open Access
- 1 September 2014
- Published by Elsevier in Molecular Therapy
- Vol. 22 (9) , 1707-1715
A Next-generation Genetically Attenuated Plasmodium falciparum Parasite Created by Triple Gene Deletion
- 1 September 2014
- Published by Elsevier in Molecular Therapy
- Vol. 22 (9) , 1707-1715
Open AccessA Next-generation Genetically Attenuated Plasmodium falciparum Parasite Created by Triple Gene Deletion